Leading In-House Life Sciences Lawyer Andrea Paul Joins WilmerHale

Paul's addition further strengthens WilmerHale's standing as a top life sciences practice.

BOSTON, Sept. 25, 2025 /PRNewswire/ -- WilmerHale is pleased to announce that Andrea Paul will join the firm's Boston office as a partner in the Life Sciences Group, effective October 6, 2025. Ms. Paul brings extensive life sciences experience advising clients on complex legal and transactional matters, including corporate governance, disclosure, capital markets, and strategic transactions.

Ms. Paul has variously served as General Counsel, Chief Legal Officer and Corporate Secretary for publicly traded life sciences companies with nationwide operations. She brings deep experience in the life sciences sector, including senior in‑house legal roles and practice at leading AmLaw 100 firms, advising on corporate and transactional matters.

"We are delighted to welcome Andrea Paul to WilmerHale. Her impressive background and client-focused approach will further strengthen our practice and enhance our services to life sciences clients across the United States and globally," said Anjan Sahni, Managing Partner of WilmerHale.

Ms. Paul's practice will focus on counseling life sciences clients across a broad range of issues, including corporate and securities, corporate governance, public offerings and other capital-raising transactions. She will also assist clients with matters involving compensation and benefits, collaborations and licensing, and M&A.

"Andrea's in-depth experience and understanding of the life sciences sector from the perspective of an outside counsel and from the inside are exceptional. Her addition to our team reflects WilmerHale's commitment to providing innovative and strategic counsel for our life sciences clients," said Judith Hasko, Co-Chair of the firm's Life Sciences Group and incoming Chair of the firm's Transactional Department.

WilmerHale's Transactional Department is recognized for its breadth and depth, serving clients in diverse industries, including life sciences, technology, finance, and private equity. The group offers comprehensive support in corporate finance, licensing, strategic alliances, mergers and acquisitions, executive compensation, tax, commercial and real estate.

"Having worked with WilmerHale for many years as a client, I am excited to join the firm and contribute to its outstanding reputation for delivering sophisticated, practical solutions to clients' most complex challenges. I look forward to supporting our clients as they work to deliver important therapies and medical solutions to patients in the dynamic life sciences industry," said Ms. Paul.

Ms. Paul was most recently Chief Legal Officer and Corporate Secretary at Zentalis Pharmaceuticals. Prior to Zentalis, she served as General Counsel and Corporate Secretary at LogicBio Therapeutics, Vice President, Legal at Akebia Therapeutics, and Senior Corporate Counsel at Momenta Pharmaceuticals.

Ms. Paul began her career at an AmLaw 50 firm in London in 2008, then moved to Boston in 2013, where she practiced at an AmLaw 100 firm until 2016.

Ms. Paul received her B.A. in Art History from Columbia University in 2003 and her J.D. from Harvard Law School in 2008, where she served as Managing Editor of The Harvard Law Review.

About Wilmer Cutler Pickering Hale and Dorr LLP
WilmerHale provides legal representation across a comprehensive range of practice areas that are critical to the success of its clients. The law firm's leading Intellectual Property, Litigation/Controversy, Regulatory and Government Affairs, Securities and Financial Services, and Transactional Departments participate in some of the highest-profile legal and policy matters. With a staunch commitment to public service, the firm is renowned as a leader in pro bono representation. WilmerHale is over 1,100 lawyers strong with 12 offices in the United States and Europe. For more information, please visit www.wilmerhale.com.

SOURCE WilmerHale